CorConsult Rx: Evidence-Based Medicine and Pharmacy

Latest Episodes:

New Drug Updates '21-'22 *ACPE-Accredited* Apr 04, 2022

Show notes

On this episode, we review several drugs that have been approved by the FDA over the last year. The list of drugs that we review are below:

Brexafemme (ibrexafungerp)
Wegovy (semaglutide)
Aducanumab (Aduhelm)
Kerendia (finerenone)
Zimhi (naloxone hydrochloride)
Tyrvaya (varenicline) Nasal Spray
PreHevbrio (hepatitis B vaccine (recombinant)
Verquvo (vericiguat)
Cabenuva (cabotegravir and rilpivirine) Extended-Release Injectable
Evkeeza (evinacumab-dgnb) Injection
Azstarys (dexmethylphenidate and serdexmethylphenidate)
Lybalvi (olanzapine and samidorphan)
Tezspire (tezepelumab-ekko) Injection
Leqvio (inclisiran) Injection
Quviviq (daridorexant)
Ruxolitinib (Opzelura) cream
Tralokinumab (Adbry)
Abrocitinib (Cibinqo)

Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We continue to partner with freeCE to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. To earn credit for this episode, visit the link provided in the show description to earn CE for listening to this podcast episode: https://hubs.ly/Q015P7cg0

For existing freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password APPROVED (all caps) to unlock the post-test for this episode.

But if you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. CorConsult Rx listeners can save 15% off the purchase of an unlimited membership by entering the discount code "PODCAST2022" at checkout, or by clicking the following link in the description https://hubs.ly/Q012N0H60

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Dry Eye Disease Mar 25, 2022

Show notes

On this episode, we discuss dry eye disease (also known as keratoconjunctivitis sicca). We give some basic background information including pathophysiology and signs/symptoms. We then compare and contrast the various artificial tear products based on the information from "Artificial tears potpourri: a literature review" (PubMed ID below). We then discuss the roles of ophth cyclosporine, ophth lifitegrast, and nasal varenicline.

PMID: 25114502

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Dermatophyte Infections *ACPE-Accredited* Mar 21, 2022

Show notes

On this episode, we review the treatment of dermatophyte (tinea) infections.

Hey guys, we're happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast! We continue to partner with freeCE to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. To earn credit for this episode, visit the link provided in the show description to earn CE for listening to this podcast episode: https://hubs.ly/Q015P7cg0

For existing freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password RINGWORM (all caps) to unlock the post-test for this episode.

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Patient Case: Newly Diagnosed DM2 and a History of CVA Mar 11, 2022

Show notes

Managing Crohn's Disease *ACPE-Accredited* Feb 26, 2022

Show notes

On this episode, we review the management of Crohn's Disease. We go over the newest guidelines and some of the supporting clinical data. We end by discussing the U.S. Preventive Services Task Force's colorectal cancer screening recommendations.

Once again, we're excited to announce that our listeners can claim ACPE-accredited continuing education for listening to our podcasts! We're partnering with freeCE by PharmCon, to provide listeners with the opportunity to claim 1-hour of continuing education credit each month. To earn credit for this episode, visit the following link for more information about earning CE for listening to our podcasts: https://hubs.ly/Q012N29c0

For freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password COLON (all caps) to unlock the post-test for this episode.

If you are not currently a freeCE member, we invite you to explore all the benefits of their Unlimited Membership on their website. CorConsult Rx listeners can receive 15% off the purchase of an unlimited membership by entering the discount code "PODCAST2022" at checkout, or by clicking the following link https://hubs.ly/Q012N0H60

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Tirzepatide: A New Frontier for Diabetes Management Feb 15, 2022

Show notes

On this episode, we review the data for tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes a new medication that is being investigated. We discuss the unique mechanism of action and summarize the data from the SURPASS studies.

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Medication Safety in Special Populations *ACPE-Accredited* Feb 07, 2022

Show notes

On this episode, we review medication regimens for special patient populations. We start with a quick overview of CYP450 drug-drug interactions. We then discuss safety conerns when starting medications in a patient that is pregnant, is at an increase risk for a bleed, renal impairment, and hepatic impairment.

For freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password SAFETY (all caps) to unlock the post-test for this episode.

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Interstitial Cystitis/ Bladder Pain Syndrome Feb 06, 2022

Show notes

The Basics of Treating Hepatitis C Jan 28, 2022

Show notes

On this episode, we discuss some of the basics of treating a patient with hepatitis C. We list the labs that should be drawn prior to starting treatment as well as non-invasive ways of assessing fibrosis/cirrhosis. We also review some information about the pangenotypic medications, Epclusa and Mavyret.

Click the following link to see the upcoming events from the Southeast Viral Hepatitis Interactive Case Confirmation (SVICC): https://www.seaetc.com/

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

A Review of SSRIs and the ANTLER Trial Jan 07, 2022

Show notes

On this episode, Cole and I are joined by Trevor Walker, PharmD Candidate 2022. We begin by comparing and contrasting the original SSRIs as well as new agents like vortioxetine and vilazodone. We then review some serotonin (5-HT) receptors and how their activity (or inhibition) determine and mitigate outcomes and adverse effects. We close by reviewing the ANTLER trial that was published in NEJM in September 2021.

Thanks for listening!

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx